Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells

Biomaterials

Volumn 97, Issue , 2016, Pages 62-73

  Wang, Hai ^a,b,c   Agarwal, Pranay ^a,b   Zhao, Shuting ^a,b   Yu, Jianhua ^c,d   Lu, Xiongbin ^e   He, Xiaoming ^a,b,c  

^a The Ohio State University   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CD44; Chemotherapy; Combination therapy; CSC; Photodynamic therapy; Photothermal therapy

Indexed keywords

CHEMOTHERAPY; DISEASES; DRUG DOSAGE; ENCAPSULATION; FULLERENES; HYALURONIC ACID; INFRARED DEVICES; INFRARED LASERS; NANOPARTICLES; ONCOLOGY; PHOTODYNAMIC THERAPY; SILICA;

CD44; COMBINATION THERAPY; DOXORUBICIN HYDROCHLORIDE; ENCAPSULATION EFFICIENCY; MULTI-FUNCTIONAL NANOPARTICLES; NEAR-INFRARED LASER IRRADIATION; PHOTOTHERMAL THERAPY; SILICA NANOPARTICLES;

LOADING;

DOXORUBICIN; FULLERENE; HERMES ANTIGEN; HYALURONIC ACID; INDOCYANINE GREEN; SILICA NANOPARTICLE; ANTINEOPLASTIC AGENT; FULLERENE C60; FULLERENE DERIVATIVE; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL DESTRUCTION; CANCER COMBINATION CHEMOTHERAPY; CANCER STEM CELL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LASER; MCF 7 CELL LINE; MOUSE; NANOENCAPSULATION; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; ANIMAL; BREAST TUMOR; CELL SURVIVAL; CHEMISTRY; DRUG RELEASE; INFRARED RADIATION; NUDE MOUSE; PATHOLOGY; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; THERMOTHERAPY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG LIBERATION; FEMALE; FULLERENES; HUMANS; HYALURONIC ACID; HYPERTHERMIA, INDUCED; INFRARED RAYS; MICE, NUDE; NANOPARTICLES; NEOPLASTIC STEM CELLS; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; SILICON DIOXIDE;

EID: 84964974564     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.04.030     Document Type: Article

References (38)

1. Prince M., Sivanandan R., Kaczorowski A., Wolf G., Kaplan M., Dalerba P., Weissman I., Clarke M., Ailles L. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:973-978.
2. Clevers H. The cancer stem cell: premises, promises and challenges. Nat. Med. 2011, 17:313-319.
3. Donnenberg V.S., Donnenberg A.D. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J. Clin. Pharmacol. 2005, 45:872-877.
4. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 2005, 5:275-284.
5. Cheng L., Wang C., Ma X., Wang Q., Cheng Y., Wang H., Li Y., Liu Z. Multifunctional upconversion nanoparticles for dual-modal imaging-guided stem cell therapy under remote magnetic control. Adv. Funct. Mater 2013, 23:272-280.
6. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
7. Wang H., Agarwal P., Zhao S., Xu R.X., Yu J., Lu X., He X. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells. Biomaterials 2015, 72:74-89.
8. Wang H., Agarwal P., Zhao S., Yu J., Lu X., He X. A near-infrared laser-activated "nanobomb" for breaking the barriers to microRNA delivery. Adv. Mater 2016, 28:347-355.
9. Jiang T., Mo R., Bellotti A., Zhou J., Gu Z. Gel-liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacy. Adv. Funct. Mater 2014, 24:2295-2304.
10. Hu Q., Sun W., Lu Y., Bomba H.N., Ye Y., Jiang T., Isaacson A.J., Gu Z. Tumor Microenvironment-mediated construction and deconstruction of extracellular drug-delivery depots. Nano. Lett. 2016, 16:1118-1126.
11. Shen S., Xia J.-X., Wang J. Nanomedicine-mediated cancer stem cell therapy. Biomaterials 2016, 74:1-18.
12. Rao W., Wang H., Han J., Zhao S., Dumbleton J., Agarwal P., Zhang W., Zhao G., Yu J., Zynger D.L., Lu X., He X. Chitosan-decorated doxorubicin-encapsulated nanoparticle targets and eliminates tumor reinitiating cancer stem-like cells. ACS Nano 2015, 9:5725-5740.
13. Bapat S.A. Human ovarian cancer stem cells. Reproduction 2010, 140:33-41.
14. Naumov G.N., Bender E., Zurakowski D., Kang S.Y., Sampson D., Flynn E., Watnick R.S., Straume O., Akslen L.A., Folkman J., Almog N. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J. Natl. Cancer Inst. 2006, 98:316-325.
15. Chuthapisith S., Eremin J., El-Sheemey M., Eremin O. Breast cancer chemoresistance: emerging importance of cancer stem cells. Surg. Oncol. 2010, 19:27-32.
16. Marotta L.L., Almendro V., Marusyk A., Shipitsin M., Schemme J., Walker S.R., Bloushtain-Qimron N., Kim J.J., Choudhury S.A., Maruyama R., Wu Z., Gonen M., Mulvey L.A., Bessarabova M.O., Huh S.J., Silver S.J., Kim S.Y., Park S.Y., Lee H.E., Anderson K.S., Richardson A.L., Nikolskaya T., Nikolsky Y., Liu X.S., Root D.E., Hahn W.C., Frank D.A., Polyak K. The JAK2/STAT3 signaling pathway is required for growth of CD44(+)CD24(-) stem cell-like breast cancer cells in human tumors. J. Clin. Invest. 2011, 121:2723-2735.
17. Korkaya H., Liu S., Wicha M.S. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J. Clin. Invest. 2011, 121:3804-3809.
18. Chin A.R., Wang S.E. Cytokines driving breast cancer stemness. Mol. Cell. Endocrinol. 2014, 382:598-602.
19. Wang H., Agarwal P., Zhao S., Yu J., Lu X., He X. A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. Nat. Commun. 2015, 6:10081.
20. Hu C.M.J., Zhang L. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem. Pharmacol. 2012, 83:1104-1111.
21. Zhang L., Gu F., Chan J., Wang A., Langer R., Farokhzad O. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 2008, 83:761-769.
22. Wang H., Yu J., Lu X., He X. Nanoparticle systems reduce systemic toxicity in cancer treatment. Nanomedicine (Lond) 2016, 11:103-106.
23. 3 nanoaggregates. Adv. Funct. Mater 2014, 24:2818-2827.
24. Chen Y., Gao Y., Chen H., Zeng D., Li Y., Zheng Y., Li F., Ji X., Wang X., Chen F. Engineering inorganic nanoemulsions/nanoliposomes by fluoride-silica chemistry for efficient delivery/co-delivery of hydrophobic agents. Adv. Funct. Mater 2012, 22:1586-1597.
25. Wang H., Zhao Y., Wu Y., Hu Y.-l, Nan K., Nie G., Chen H. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 2011, 32:8281-8290.
26. Song X., Zhang R., Liang C., Chen Q., Gong H., Liu Z. Nano-assemblies of J-aggregates based on a NIR dye as a multifunctional drug carrier for combination cancer therapy. Biomaterials 2015, 57:84-92.
27. Mukerji R., Schaal J., Li X., Bhattacharyya J., Asai D., Zalutsky M.R., Chilkoti A., Liu W. Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumor. Biomaterials 2016, 79:79-87.
28. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Gene Dev. 2003, 17:1253-1270.
29. Zuo Z.Q., Chen K.G., Yu X.Y., Zhao G., Shen S., Cao Z.T., Luo Y.L., Wang Y.C., Wang J. Promoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-beta signaling pathway inhibition. Biomaterials 2016, 82:48-59.
30. Zhang Z., Wang L., Wang J., Jiang X., Li X., Hu Z., Ji Y., Wu X., Chen C. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv. Mater 2012, 24:1418-1423.
31. Zheng M., Yue C., Ma Y., Gong P., Zhao P., Zheng C., Sheng Z., Zhang P., Wang Z., Cai L. Single-step assembly of DOX/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy. Acs Nano 2013, 7:2056-2067.
32. Yu J., Javier D., Yaseen M.A., Nitin N., Richards-Kortum R., Anvari B., Wong M.S. Self-assembly synthesis, tumor cell targeting, and photothermal capabilities of antibody-coated indocyanine green nanocapsules. J. Am. Chem. Soc. 2010, 132:1929-1938.
33. Rao W., Zhao S., Yu J., Lu X., Zynger D.L., He X. Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsules. Biomaterials 2014, 35:7762-7773.
34. Foster B.A., Gangavarapu K.J., Mathew G., Azabdaftari G., Morrison C.D., Miller A., Huss W.J. Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme. PLoS One 2013, 8:e55062.
35. Riechelmann H., Sauter A., Golze W., Hanft G., Schroen C., Hoermann K., Erhardt T., Gronau S. Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma. Oral Oncol. 2008, 44:823-829.
36. Orian-Rousseau V. CD44, a therapeutic target for metastasising tumours. Eur. J. Cancer 2010, 46(7):1271-1277.
37. Naor D., Nedvetzki S., Golan I., Melnik L., Faitelson Y. CD44 in cancer. Crit. Rev. Clin. Lab. Sci. 2002, 39:527-579.
38. Baccelli I., Trumpp A. The evolving concept of cancer and metastasis stem cells,. J. Cell Biol. 2012, 198:281-293.